Thalassemia patient received successful transplantation by cord blood bank
Motherhood is a blessing for every mother and every woman dreams about it. There would be no single mother who does not pray for the good health of her child. Nowadays, medical science has provided present mothers with a valuable chance to decide their child's future. It has been possible only because of the stem cells which can cure several diseases. These stem cells were however were extracted from the embryos and adult tissues in the past. However, due to many controversies associated with their use, scientists have kept looking for other resources as well. Umbilical cord which is the cord connected to the baby from the mother has been found to be a precious source for cord blood stem cells
CordLife-India is among one of the advanced cord blood banks with its headquarters in Singapore. It is managed at the international level. The bank provides facilities for the stem cells storage taken from the umbilical cord of baby. With use of patented technology, this cord blood bank provides safe storage of the stem cells. It is a useful fact that stem cells have the ability to cure about 80 different kinds of diseases. With the discovery that cord blood is a valuable resource of stem cells and also bone marrow, the doctors are alleging that there is ninety percent hope for cure of the Thalassemia patients.
One of its units is located in Kolkata, India that is known for its cryogenic cord blood preservation and the possibility to use stored cells in the entire Asia-Pacific region. Thalassemia is a blood disease which is an inherited disorder and results in abnormal hemoglobin formation in the blood. This then causes huge destruction of the red blood cells causing anemia. The babies suffering from this disease have life expectancy of a few years. Bone marrow transplantation has been proved to be successful by the treatment of stored stem cells. The only hurdle at this time is to find an exact match of bone marrow donor which is difficult.
This is why the use of cord blood extracted stem cells seems an excellent alternative. Moreover, there is no risk of auto immune rejection of cells due to hundred percent matches to the stem cells. Working on this principle recently, CordLife got success in cord blood transplant in a five year old child suffering from Thalassemia. According to the CordLife- India Medical Director Dr Prosanto Chowdury – the stem cells transplantation process is a very complicated method. It is due to the fact that it requires compatibility with HLA and count of stem cells. The stem cell count of transplantation unit with the recipient weight of the body is called cell dose. It is an important factor to determine the success rate of transplant.
Under the conditions such as hematological growth, it is must to do stem cells procurement and transplantation at an early stage for survival. The key factor to the success of the transplantation method is the stem cells preservation and their right usage at the right time. By successfully curing diseases like blood cancer and cerebral palsy, the bank has added one more milestone in its story of successful transplantation cases.
CordLife-India is among one of the advanced cord blood banks with its headquarters in Singapore. It is managed at the international level. The bank provides facilities for the stem cells storage taken from the umbilical cord of baby. With use of patented technology, this cord blood bank provides safe storage of the stem cells. It is a useful fact that stem cells have the ability to cure about 80 different kinds of diseases. With the discovery that cord blood is a valuable resource of stem cells and also bone marrow, the doctors are alleging that there is ninety percent hope for cure of the Thalassemia patients.
One of its units is located in Kolkata, India that is known for its cryogenic cord blood preservation and the possibility to use stored cells in the entire Asia-Pacific region. Thalassemia is a blood disease which is an inherited disorder and results in abnormal hemoglobin formation in the blood. This then causes huge destruction of the red blood cells causing anemia. The babies suffering from this disease have life expectancy of a few years. Bone marrow transplantation has been proved to be successful by the treatment of stored stem cells. The only hurdle at this time is to find an exact match of bone marrow donor which is difficult.
This is why the use of cord blood extracted stem cells seems an excellent alternative. Moreover, there is no risk of auto immune rejection of cells due to hundred percent matches to the stem cells. Working on this principle recently, CordLife got success in cord blood transplant in a five year old child suffering from Thalassemia. According to the CordLife- India Medical Director Dr Prosanto Chowdury – the stem cells transplantation process is a very complicated method. It is due to the fact that it requires compatibility with HLA and count of stem cells. The stem cell count of transplantation unit with the recipient weight of the body is called cell dose. It is an important factor to determine the success rate of transplant.
Under the conditions such as hematological growth, it is must to do stem cells procurement and transplantation at an early stage for survival. The key factor to the success of the transplantation method is the stem cells preservation and their right usage at the right time. By successfully curing diseases like blood cancer and cerebral palsy, the bank has added one more milestone in its story of successful transplantation cases.
Source...